Arginase Inhibitors

Santa Cruz Biotechnology now offers a broad range of Arginase Inhibitors for use in various applications. Arginase inhibitors are a crucial category of compounds in scientific research, particularly in the study of nitrogen metabolism and the urea cycle. Arginase is an enzyme that catalyzes the hydrolysis of arginine into ornithine and urea, a key step in the detoxification of ammonia in the liver. By inhibiting arginase, researchers can explore its role in various metabolic pathways, particularly those involved in amino acid metabolism and nitric oxide production. These inhibitors are invaluable in studies aimed at understanding the regulation of arginine availability, which is essential for protein synthesis and the production of polyamines, proline, and other metabolites. Arginase inhibitors are also used to investigate the enzyme's role in modulating nitric oxide levels, as arginine is a common substrate for both arginase and nitric oxide synthase. The inhibition of arginase allows for increased availability of arginine for nitric oxide production, providing insights into how this balance affects various physiological processes. Additionally, these inhibitors are employed in research exploring the broader implications of arginase activity in areas such as immunology, where the enzyme plays a role in immune cell function and inflammation. The availability of a diverse range of arginase inhibitors enables researchers to tailor their experimental approaches to specific aspects of arginase function, advancing our understanding of its role in cellular metabolism and its potential impact on various biological systems. View detailed information on our available Arginase Inhibitors by clicking on the product name.